CGON Announces Ambaw Bellete's Separation Effective June 30, 2026, Appoints Arthur Kuan as President
CG Oncology, Inc. Common stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $62.29
-5.4% in 1d after detection
Post-detection moves
1h
0.0%
1d
-5.4%
3d
-3.1%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS